Advertisement

Topics

Peregrine Pharmaceuticals Company Profile

21:25 EDT 18th June 2018 | BioPortfolio

Peregrine Pharmaceuticals, Inc. (NASDAQ-PPHM) is a clinical stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and hepatitis C virus (HCV) infection. The Company is advancing three separate clinical programs with its lead product candidates bavituximab and Cotara®. Bavituximab and Cotara are both in Phase II clinical studies for the treatment of cancer. In addition, bavituximab is also in a Phase I clinical study for the treatment of HCV infection.

The Company also provides comprehensive biomanufacturing services for both Peregrine and outside customers through its wholly-owned subsidiary, Avid Bioservices, Inc.

Location

14282 Franklin Avenue
Tustin
CA
92780
United States of America

Contact

Phone: 714-508-6000
Fax: 714-838-5817
Email: pr@peregrineinc.com


News Articles [482 Associated News Articles listed on BioPortfolio]

Reviewing Horizon Therapeutics

Horizon Therapeutics and Peregrine Pharmaceuticals are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their profitabi...

SoCal's Peregrine Names a New CEO, to Change Name to Avid Bioservices

Dr. Lias succeeds Steven W. King, who resigned as president and chief executive officer of Peregrine to pursue other professional interests.

Appointments: Neurotrope, Concert, Lannett, Peregrine, Allergan, Amneal, Acticor, Alliance Pharma

The latest biopharma industry appointments include new CEOs at Neurotrope, Lannett, Amneal and Peregrine Pharmaceuticals, a new CFO at Concert...   

Peregrine Pharmaceuticals to Present at Biotech Showcase 2018

TUSTIN, Calif., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a company committed to improving patient lives by manufacturing and delivering high...

Peregrine Pharmaceuticals Appoints New CEO

Roger Lias currently sits on the company's board of directors

Peregrine Pharmaceuticals Announces Appointment of Roger J. Lias, Ph.D., as President and Chief Executive Officer

TUSTIN, Calif., Dec. 26, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a company committed to improving patient lives by manufacturing and delivering high...

Peregrine Pharmaceuticals Announces Name Change to Avid Bioservices as Part of Transition to Dedicated Contract Development and Manufacturing Organization (CDMO)

TUSTIN, Calif., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a company working to improve patient lives by providing high quality biologics ma...

Management tracks: Vivus, Peregrine

Drugs and Medications [270 Associated Drugs and Medications listed on BioPortfolio]

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

Eyewash station additive concentrate [Niagara Pharmaceuticals Inc.]

EYEWASH STATION ADDITIVE CONCENTRATE

PubMed Articles [138 Associated PubMed Articles listed on BioPortfolio]

Experimental observation of the emergence of Peregrine-like events in focusing dam break flows.

Simple photonic fiber-based workbenches have been able to emulate well-known nonlinear wave dynamics occurring in deep or shallow water conditions. Here, by investigating the nonlinear reshaping of a ...

Intraspecific evolutionary relationships among peregrine falcons in western North American high latitudes.

Subspecies relationships within the peregrine falcon (Falco peregrinus) have been long debated because of the polytypic nature of melanin-based plumage characteristics used in subspecies designations ...

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product ...

Clinical Trials [219 Associated Clinical Trials listed on BioPortfolio]

A Pilot Study to Investigate the Clinical Utility of the Peregrine Monte Carlo Dose Calculation System for Radiation Therapy Treatment Planning

The utility of PEREGRINE Monte Carlo calculations for radiation treatment planning in a clinical setting will be assessed by comparing results with other fully three-dimensional programs. ...

The Peregrine Post-Market Study

The Ablative Solutions, Inc. Peregrine System Infusion Catheter is a catheter-based device which is intended to be used to ablate the afferent and efferent sympathetic nerves serving the k...

The Peregrine Study: A Safety and Performance Study of Renal Denervation

The Ablative Solutions, Inc. Peregrine System Infusion Catheter is a catheter-based device which is intended to be used to ablate the afferent and efferent sympathetic nerves serving the k...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Companies [1323 Associated Companies listed on BioPortfolio]

Peregrine Pharmaceuticals, Inc.

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of cancer and serious viral infections. The co...

Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. (NASDAQ-PPHM) is a clinical stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and hepatitis C virus (HCV) infectio...

deltaDOT Ltd

deltaDOT Ltd (www.deltadot.com) is a biotechnology company that is developing and commercialising highly innovative enabling technologies and products for the separation and analysis of biomolecules. ...

CartiHeal

Founded in 2009, at Incentive, Peregrine Ventures incubator, CartiHeal is a privately held medical device company that develops proprietary implants for the regeneration of cartil...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

More Information about "Peregrine Pharmaceuticals" on BioPortfolio

We have published hundreds of Peregrine Pharmaceuticals news stories on BioPortfolio along with dozens of Peregrine Pharmaceuticals Clinical Trials and PubMed Articles about Peregrine Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Peregrine Pharmaceuticals Companies in our database. You can also find out about relevant Peregrine Pharmaceuticals Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...


Corporate Database Quicklinks



Searches Linking to this Company Record